Phathom Pharmaceuticals Inc
NASDAQ:PHAT

Watchlist Manager
Phathom Pharmaceuticals Inc Logo
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Watchlist
Price: 7.36 USD -3.29%
Market Cap: 503.3m USD
Have any thoughts about
Phathom Pharmaceuticals Inc?
Write Note

DCF Value

This DCF valuation model was created by Alpha Spread and was last updated on Dec 24, 2024.

Estimated DCF Value of one PHAT stock is 9.05 USD. Compared to the current market price of 7.36 USD, the stock is Undervalued by 19%.

PHAT DCF Value
Base Case
9.05 USD
Undervaluation 19%
DCF Value
Price
Worst Case
Base Case
Best Case
9.05
DCF Value
Worst Case
Base Case
Best Case
Hide
DCF Value: 9.05 USD

Present Value Calculation

This block is the starting point of the DCF valuation process. It calculates the present value of a company's forecasted cash flows based on selected operating model. Adjust key parameters like discount rate and terminal growth, and alter inputs such as revenue growth and margins to see their impact on valuation.

DCF Model
Base Case Scenario

The present value of cash flows over the next 5 years amounts to -360m USD. The present value of the terminal value is 1B USD. The total present value equals 675.4m USD.
Forecast Period
Years
Discount Rate
%
Show All DCF Settings
Terminal Growth
%
Hide DCF Settings
Save

DCF Value Calculation

This stage translates the present value into DCF value per share. For firm valuation models, it adjusts present value for debt and assets to derive equity value (skipped if using equity valuation model). Finally, this equity value is divided by the number of shares to determine the DCF value per share.

Present Value to DCF Value
Capital Structure

Present Value 675.4m USD
+ Cash & Equivalents 381.4m USD
Firm Value 1.1B USD
- Debt 437.7m USD
Equity Value 619.1m USD
/ Shares Outstanding 68.4m
PHAT DCF Value 9.05 USD
Undervalued by 19%

Valuation Analysis

Sensitivity Analysis
DCF Value Sensitivity Analysis

Sensitivity Analysis assesses how changes in key factors like revenue growth, margin, and discount rate affect a stock's DCF value. By visualizing various scenarios, from significant downturns to optimistic growth, this tool helps you understand potential valuation shifts, aiding in risk assessment and strategic decision-making.

DCF Financials
Financials used in DCF Calculation

Revenue
52.7m 1.3B
Operating Income
-281.3m 193.5m
FCFF
-265.3m 112.1m

See Also

Discover More

What is the DCF value of one PHAT stock?

Estimated DCF Value of one PHAT stock is 9.05 USD. Compared to the current market price of 7.36 USD, the stock is Undervalued by 19%.

The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock DCF values gives a complete picture of the investment risks and opportunities.

How was the DCF Value calculated?

1. Present Value Calculation. Utilizing the DCF operating model, Phathom Pharmaceuticals Inc's future cash flows are projected and then discounted using a chosen discount rate to determine its Present Value, which is calculated at 675.4m USD.

2. DCF Value Calculation. The company's capital structure is employed to derive the total Equity Value from the previously calculated Present Value of the cash flow. This Equity Value, when divided by the total number of outstanding shares, yields the DCF Value of 9.05 USD per share.

Back to Top
//